Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center Randomized Controlled Trial on Mevalproic Acid Improving Oocyte Quality and Embryo Development in Elderly Infertile Patients

NCT05788822 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.

NCT NCT05788822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center Randomized Controlled Trial on Mevalproic Acid Improving Oocyte Quality and Embryo Development in Elderly Infertile Patients
Lead sponsor
Nanjing University
Phase
Not applicable
Overall status
Unknown status
Start date
October 8, 2022
Completion date
December 31, 2025
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female, ivf, oocyte, reproductive disorder